All Stories

  1. CSF TACI and BAFF levels in patients with primary CNS lymphoma as novel diagnostic biomarkers

    Article • Annals of Clinical and Translational Neurology, October 2018, Wiley

    Dr. Akitake Mukasa

  2. SIRT2‐mediated inactivation of p73 is required for glioblastoma tumorigenicity

    Article • EMBO Reports, September 2018, EMBO

    Dr. Akitake Mukasa

  3. Concomitant administration of radiation with eribulin improves the survival of mice harboring intracerebral glioblastoma

    Article • Cancer Science, June 2018, Wiley

    Dr. Akitake Mukasa

  4. IDH -mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis

    Article • Cancer Science, June 2018, Wiley

    Dr. Akitake Mukasa, Phyo Kim

  5. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma

    Article • Journal of Neurosurgery, May 2018, Journal of Neurosurgery Publishing Group (JNSPG)

    Dr. Akitake Mukasa

  6. Identification of a novel fusion gene HMGA2-EGFR in glioblastoma

    Article • International Journal of Cancer, December 2017, Wiley

    Dr. Akitake Mukasa

  7. a member of neurooncology prigram

    Article • Journal of Neurosurgery Spine, March 2017, Journal of Neurosurgery Publishing Group (JNSPG)

    Dr. Akitake Mukasa, Mr Shunsuke SY Yanagisawa, Masao Matsutani